top of page

SARS-CoV-2 is associated with changes in brain structure in UK Biobank


  • AUTHORS:

  • Gwenaëlle Douaud, Soojin Lee, Fidel Alfaro-Almagro, Christoph Arthofer, Chaoyue Wang, Paul McCarthy, Frederik Lange, Jesper L. R. Andersson, Ludovica Griffanti,

  • Eugene Duff, Saad Jbabdi, Bernd Taschler, Peter Keating, Anderson M. Winkler,

  • Rory Collins, Paul M. Matthews, Naomi Allen, Karla L. Miller, Thomas E. Nichols &

  • Stephen M. Smith


Abstract

There is strong evidence for brain-related abnormalities in COVID-191–13. It remains unknown however whether the impact of SARS-CoV-2 infection can be detected in milder cases, and whether this can reveal possible mechanisms contributing to brain pathology. Here, we investigated brain changes in 785 UK Biobank participants (aged 51–81) imaged twice, including 401 cases who tested positive for infection with SARS-CoV-2 between their two scans, with 141 days on average separating their diagnosis and second scan, and 384 controls. The availability of pre-infection imaging data reduces the likelihood of pre-existing risk factors being misinterpreted as disease effects. We identified significant longitudinal effects when comparing the two groups, including: (i) greater reduction in grey matter thickness and tissue-contrast in the orbitofrontal cortex and parahippocampal gyrus, (ii) greater changes in markers of tissue damage in regions functionally-connected to the primary olfactory cortex, and (iii) greater reduction in global brain size. The infected participants also showed on average larger cognitive decline between the two timepoints. Importantly, these imaging and cognitive longitudinal effects were still seen after excluding the 15 cases who had been hospitalised. These mainly limbic brain imaging results may be the in vivo hallmarks of a degenerative spread of the disease via olfactory pathways, of neuroinflammatory events, or of the loss of sensory input due to anosmia. Whether this deleterious impact can be partially reversed, or whether these effects will persist in the long term, remains to be investigated with additional follow up.


DOWNLOAD THE ENTIRE ARTICLE HERE


21 views0 comments

Recent Posts

See All

This article was published by the New York Post on February 27,2023. Author is Marty Makary MD, MPH a professor at the Johns Hopkins University School of Medicine and author of “The Price We Pay.” I

NAC is a natural antioxidant produced by the body. It is used to synthesize Glutathione (the most potent antioxidant in the body) within the blood. NAC is the precursor for Glutathione. This means tha

bottom of page